Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb

被引:48
作者
Hourcade, DE
Mitchell, L
Kuttner-Kondo, LA
Atkinson, JP
Medof, ME
机构
[1] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA
[2] Case Western Reserve Univ, Dept Pathol & Med, Cleveland, OH 44106 USA
关键词
D O I
10.1074/jbc.M109322200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The AP C3 convertase, C3bBb(Mg2+), is subject to irreversible dissociation (decay acceleration) by three proteins: DAF, CR1, and factor H. We have begun to map the factor B (fB) sites critical to these interactions. We generated a panel of fB mutations, focusing on the type A domain because it carries divalent cation and C3b-binding elements. C3bBb complexes were assembled with the mutants and subjected to decay acceleration. Two critical fB sites were identified with a structural model. 1) Several mutations centered at adjacent alpha helices 4 and 5 (Gln-335, Tyr-338, Ser-339, Asp-382) caused substantial resistance to DAF and CR1-mediated decay acceleration but not factor H. 2) Several mutations centered at the alpha I helix and adjoining loops (especially D254G) caused resistance to decay acceleration mediated by all three regulators and also increased C3b-binding affinity and C3bBb stability. In the simplest interpretation of these results, DAF and CRI directly interact with C3bBb at alpha 4/5; factor H likely interacts at some other location, possibly on the C3b subunit. Mutations at the C3b.Bb interface interfere with the normal dissociation of C3b from Bb, whether it is spontaneous or promoted by DAF, CR1, or factor H.
引用
收藏
页码:1107 / 1112
页数:6
相关论文
共 33 条
[1]  
[Anonymous], HUMAN COMPLEMENT SYS
[2]   Anatomy of hot spots in protein interfaces [J].
Bogan, AA ;
Thorn, KS .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 280 (01) :1-9
[3]  
Brodbeck WG, 1996, J IMMUNOL, V156, P2528
[4]   Structure/function studies of human decay-accelerating factor [J].
Brodbeck, WG ;
Kuttner-Kondo, L ;
Mold, C ;
Medof, ME .
IMMUNOLOGY, 2000, 101 (01) :104-111
[5]  
Carroll MC, 1998, CURR OPIN IMMUNOL, V10, P36
[6]   Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib [J].
Emsley, J ;
Cruz, M ;
Handin, R ;
Liddington, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (17) :10396-10401
[7]   Elements of immunity - The instructive role of innate immunity in the acquired immune response [J].
Fearon, DT ;
Locksley, RM .
SCIENCE, 1996, 272 (5258) :50-54
[8]   Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: Implications for the activity of factor B [J].
Hinshelwood, J ;
Spencer, DIR ;
Edwards, YJK ;
Perkins, SJ .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 294 (02) :587-599
[9]   Metal-dependent conformational changes in a recombinant vWF-A domain from human factor B:: A solution study by circular dichroism, Fourier transform infrared and 1H NMR spectroscopy [J].
Hinshelwood, J ;
Perkins, SJ .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 298 (01) :135-147
[10]  
HOURCADE D, 1989, PROG IMMUNOL, V7, P171